Last updated on September 2018

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo


Brief description of study

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.

Clinical Study Identifier: NCT00351611

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

David M Klein, MD, PA
Port Charlotte, FL United States
  Connect »

Pfizer CT.gov Call Center

Medsol Clinical Research Center
Port Charlotte, FL United States
2.81miles
  Connect »